Voloridge Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-938,715
| Closed | -$78.8M | – | 1283 |
|
|
2025
Q3 | $78.8M | Sell |
938,715
-807,416
| -46% | -$66.5M | 0.26% | 99 |
|
|
2025
Q2 | $138M | Buy |
1,746,131
+72,237
| +4% | +$5.74M | 0.51% | 32 |
|
|
2025
Q1 | $150M | Sell |
1,673,894
-646,912
| -28% | -$60.4M | 0.56% | 16 |
|
|
2024
Q4 | $231M | Buy |
2,320,806
+367,524
| +19% | +$37.9M | 0.82% | 5 |
|
|
2024
Q3 | $222M | Buy |
1,953,282
+819,375
| +72% | +$97.3M | 0.81% | 5 |
|
|
2024
Q2 | $140M | Buy |
1,133,907
+1,084,512
| +2,196% | +$140M | 0.52% | 25 |
|
|
2024
Q1 | $6.52M | Sell |
49,395
-778,393
| -94% | -$95.9M | 0.02% | 580 |
|
|
2023
Q4 | $90.2M | Buy |
+827,788
| New | +$85.9M | 0.36% | 72 |
|
|
2022
Q2 | – | Sell |
-358,221
| Closed | -$29.4M | – | 1568 |
|
|
2022
Q1 | $29.4M | Buy |
+358,221
| New | +$28.2M | 0.17% | 166 |
|
|
2021
Q4 | – | Sell |
-219,887
| Closed | -$16.5M | – | 1742 |
|
|
2021
Q3 | $16.5M | Buy |
219,887
+217,279
| +8,331% | +$16.5M | 0.11% | 263 |
|
|
2021
Q2 | $203K | Sell |
2,608
-47,683
| -95% | -$3.55M | ﹤0.01% | 1563 |
|
|
2021
Q1 | $3.7M | Buy |
50,291
+31,673
| +170% | +$2.34M | 0.03% | 625 |
|
|
2020
Q4 | $1.45M | Buy |
+18,618
| New | +$1.42M | 0.01% | 850 |
|
|
2020
Q3 | – | Sell |
-832,892
| Closed | -$61.5M | – | 1409 |
|
|
2020
Q2 | $61.5M | Buy |
832,892
+470,958
| +130% | +$35.5M | 0.7% | 23 |
|
|
2020
Q1 | $26.6M | Sell |
361,934
-229,797
| -39% | -$18.1M | 0.76% | 22 |
|
|
2019
Q4 | $51.4M | Buy |
591,731
+324,385
| +121% | +$26.6M | 1% | 7 |
|
|
2019
Q3 | $21.5M | Buy |
267,346
+180,348
| +207% | +$14.5M | 0.37% | 36 |
|
|
2019
Q2 | $6.96M | Buy |
86,998
+44,124
| +103% | +$3.38M | 0.19% | 110 |
|
|
2019
Q1 | $3.4M | Buy |
+42,874
| New | +$3.21M | 0.1% | 191 |
|
|
2017
Q3 | – | Sell |
-1,528,165
| Closed | -$93.5M | – | 479 |
|
|
2017
Q2 | $93.5M | Buy |
1,528,165
+374,498
| +32% | +$22.8M | 2.33% | 4 |
|
|
2017
Q1 | $69.9M | Buy |
+1,153,667
| New | +$70M | 1.7% | 10 |
|
|
2016
Q4 | – | Sell |
-1,766,199
| Closed | -$105M | – | 652 |
|
|
2016
Q3 | $105M | Buy |
1,766,199
+1,437,688
| +438% | +$84.1M | 2.29% | 3 |
|
|
2016
Q2 | $18.1M | Sell |
328,511
-630,304
| -66% | -$33.5M | 0.52% | 59 |
|
|
2016
Q1 | $48.4M | Buy |
958,815
+934,905
| +3,910% | +$45.8M | 1.13% | 14 |
|
|
2015
Q4 | $1.21M | Buy |
+23,910
| New | +$1.21M | 0.09% | 140 |
|
Other funds holding MRK
Voloridge Investment Management's MRK Position: Q4 2025 in Review
Voloridge Investment Management sold out of Merck (MRK) in Q4 2025, closing a stake of 938,715 shares — an estimated $78.8M sold.
Voloridge Investment Management first reported a position in MRK in Q4 2015 and held it in 25 quarters. The position peaked at $231M in Q4 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Voloridge Investment Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Voloridge Investment Management sold 938,715 Merck shares in Q4 2025, an estimated $78.8M.
- Voloridge Investment Management first reported a position in Merck in Q4 2015 and held it in 25 quarters.
- Voloridge Investment Management's Merck position peaked at $231M in Q4 2024.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.